Back to Dashboard
GSK · Healthcare

Gsk Plc

Europe Healthcare Filing: 2026-06-30
26/100
Smart-money confidence1 of 3 sources positive
Below average interest

No standout activity across the feeds we track.

What this band has actually done: stocks scoring 25–45 beat the S&P 500 over the next three months 45.3% of the time, across 39,662 cases since 2015. That is below a coin flip — and so is every other band, because the median stock loses to a cap-weighted index. How we measured this

Hedge funds
35
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Market cap
$98.6B
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NYSE
About GSK PLC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis,…

Who's behind the signal
Every informed buyer we can see on GSK, across all three feeds.
Hedge funds · 7
Point72 (Steve Cohen) New position
D.E. Shaw & Co New position
Citadel Advisors New position
AQR Capital Management Increased +22%
Dodge & Cox Decreased −18%
Tweedy Browne Unchanged
+1 more in the full breakdown below ↓
Congress · 11
Lisa C. McClain sold
Val T. Hoyle sold
Robert B. Aderholt sold
Bruce Westerman sold
Marjorie Taylor Greene bought
Daniel S. Goldman sold
Virginia Foxx sold
John H. Rutherford sold
+3 more in the full record below ↓
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 39 on record
Disclosures from 2017-03-16 to 2025-10-31
Trade date Member Chamber Action Amount
2025-10-31 Lisa C. McClain · R-MI House Sold $1,001 - $15,000
2025-10-30 Lisa C. McClain · R-MI House Bought $1,001 - $15,000
2025-10-30 Lisa C. McClain · R-MI House Sold $1,001 - $15,000
2025-09-23 Val T. Hoyle · D-OR House Sold $1,001 - $15,000
2025-08-04 Lisa C. McClain · R-MI House Bought $1,001 - $15,000
2025-07-28 Robert B. Aderholt · R-AL House Sold $1,001 - $15,000
2025-06-24 Lisa C. McClain · R-MI House Sold $1,001 - $15,000
2025-06-17 Lisa C. McClain · R-MI House Bought $1,001 - $15,000
2025-04-21 Bruce Westerman · R-AR House Sold $1,001 - $15,000
2025-03-03 Bruce Westerman · R-AR House Bought $1,001 - $15,000
Show the other 29
Trade date Member Chamber Action Amount
2024-11-25 Marjorie Taylor Greene · R-GA House Bought $1,001 - $15,000
2024-11-18 Val T. Hoyle · D-OR House Bought $1,001 - $15,000
2023-07-10 Daniel S. Goldman · D-NY House Sold $15,001 - $50,000
2023-03-01 Virginia Foxx · R-NC House Sold $50,001 - $100,000
2022-08-16 Virginia Foxx · R-NC House Bought $1,001 - $15,000
2022-08-10 Virginia Foxx · R-NC House Bought $15,001 - $50,000
2022-08-09 Virginia Foxx · R-NC House Bought $1,001 - $15,000
2022-08-05 Virginia Foxx · R-NC House Bought $15,001 - $50,000
2022-07-12 Virginia Foxx · R-NC House Sold $100,001 - $250,000
2022-07-06 Virginia Foxx · R-NC House Bought $1,001 - $15,000
2022-04-08 Virginia Foxx · R-NC House Bought $1,001 - $15,000
2022-02-22 Virginia Foxx · R-NC House Bought $1,001 - $15,000
2022-02-17 John H. Rutherford · R-FL House Sold $1,001 - $15,000
2022-01-14 Virginia Foxx · R-NC House Bought $1,001 - $15,000
2021-10-08 Virginia Foxx · R-NC House Bought $1,001 - $15,000
2021-07-09 Virginia Foxx · R-NC House Bought $1,001 - $15,000
2021-06-04 Katherine M. Clark · D-MA House Sold $1,001 - $15,000
2021-04-09 Virginia Foxx · R-NC House Bought $1,001 - $15,000
2021-01-15 Virginia Foxx · R-NC House Bought $1,001 - $15,000
2020-11-05 Katherine M. Clark · D-MA House Bought $1,001 - $15,000
2020-10-22 Katherine M. Clark · D-MA House Sold $1,001 - $15,000
2020-10-09 Virginia Foxx · R-NC House Bought $1,001 - $15,000
2020-07-10 Virginia Foxx · R-NC House Bought $1,001 - $15,000
2020-04-13 Virginia Foxx · R-NC House Bought $15,001 - $50,000
2020-03-18 Greg Gianforte · R-MT House Bought $50,001 - $100,000
2020-03-02 Katherine M. Clark · D-MA House Bought $1,001 - $15,000
2020-01-10 Virginia Foxx · R-NC House Bought $1,001 - $15,000
2017-06-15 Patty Murray · D-WA Senate Sold $1,001 - $15,000
2017-03-16 Patty Murray · D-WA Senate Bought $1,001 - $15,000
Not a model pick — but on our radar. GSK PLC isn't in the top-10 model right now, but 7 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
7
Investors
3
New positions
1
Increasing
2
Decreasing
1
Unchanged
Price History
Loading price data...
A member of Congress bought A member sold
Return: High: Low:

Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.

Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Portfolio Allocation
How much of each investor's portfolio is allocated to GSK PLC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell GSK PLC or any security.

Get the Weekly Update

Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime
© 2026 Big Money Radar  ·  Not financial advice  ·  Data delayed up to 135 days Methodology  ·  Data sources  ·  Contact  ·  API